Understand the risk and biology of smouldering myeloma (SMM) for early detection of symptomatic myeloma. The study will investigate genomic and immune correlates of progression, clonal heterogeneity, and biomarkers using liquid biopsies and T cell phenotype and functionality in SMM.

4 views • 15 slides

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th - 21st June 2024 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.\n\nEnquire Now @ https:\/\/events.marketsandmarkets.com\/2nd-annual-

4 views • 5 slides

Alinity i STAT High Sensitivity Troponin-I is a proprietary assay used in diagnosing myocardial infarction (MI) by quantitatively measuring cardiac troponin I in human plasma. This chemiluminescent microparticle immunoassay (CMIA) aids in the detection of MI, a significant aspect in managing heart d

2 views • 30 slides

Willow Health presents an innovative AI companion, Willow, designed for personalized brain health monitoring and intervention. Their team, comprising students, scientists, doctors, and entrepreneurs, is dedicated to advancing brain health through continuous monitoring and improvement using digital a

2 views • 17 slides

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th - 21st June 2024 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.\n\nBecome a Speaker @ \/\/events.marketsandmarkets.com\/2nd-annual-b

1 views • 6 slides

Biomarkers are either released by the human body in response to various diseases or by organs that are affected by the disease, such as tumors. Biomarkers are being used increasingly to detect several infectious and chronic diseases, such as cancer, neurological disorders, cardiovascular diseases, a

1 views • 2 slides

The Global Renal Biomarkers Market Size is Anticipated to Exceed USD 3,081.6 Million by 2033, Growing at a CAGR of 7.53% from 2023 to 2033.\n\n

0 views • 5 slides

Semaglutide, a GLP-1 receptor agonist, shows promising effects on physical function, body composition, and aging biomarkers in older adults with diabetes. Studies suggest potential neuroprotective effects, improvement in skeletal muscle atrophy, and reduction in pro-inflammatory markers. Diabetes pr

0 views • 23 slides

The Global Digital Biomarkers Market size is expected to be worth around USD 24.3 Billion by 2033, from USD 3.4 Billion in 2023, growing at a CAGR of 21.7% during the forecast period from 2024 to 2033.

0 views • 2 slides

Industrial toxicology is a vital field that studies the effects of various agents on organism health through mechanisms of action, toxicokinetics, and more. It explores toxic chemical absorption, distribution, metabolism, and elimination, as well as toxic effects on major organ systems. Learn about

0 views • 35 slides

Translational Liver Consortia (TLC) and the Translational Hepatocellular Carcinoma Consortium (THCCC) led by Dr. Hashem B. El-Serag are focused on advancing research for early detection of liver cancer. The main objectives include patient stratification for liver cancer risk, surveillance in cirrhos

0 views • 25 slides

Dementia, a syndrome resulting from various diseases affecting nerve cells and brain function, leads to cognitive decline. Treatment approaches include pharmacological and non-pharmacological interventions such as biomarker monitoring, lifestyle modifications, and addressing risk factors like hypert

0 views • 12 slides

These slides provide an in-depth overview of the EASL clinical practice guidelines on managing drug-induced liver injury. The guidelines cover epidemiology, key recommendations, future prospects, new biomarkers, unresolved issues, and unmet needs. Recommendations are based on evidence levels from th

0 views • 44 slides

European Patients Academy on Therapeutic Innovation explains how biomarkers are measurable indicators providing insights into health conditions. Biomarkers like glucose levels in diabetes management and MRI imaging for Multiple Sclerosis play crucial roles. The Academy aims to enhance the medicine d

0 views • 24 slides

The Mohan Research Lab offers undergraduates the chance to conduct impactful research that can be published, focusing on biomarkers and targets for autoimmune diseases and cancers. Led by an international team of researchers, the lab provides a collaborative environment for students to engage in cut

4 views • 12 slides

Colorado's comprehensive cancer programs are focusing on enhancing cancer surveillance by collecting biomarkers and prognostic factors statewide. The initiative involves multi-phase implementation, bidirectional reporting for genetic counseling services, and increasing testing for targeted therapies

4 views • 17 slides

The Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) commenced in late 2006, with a cohort size and follow-up progress detailed. The study includes assessments and biomarker imaging, such as MRI, amyloid PET, and tau PET scans, with ongoing review cycles and data additions. Current

0 views • 12 slides

growing research activities in developing countries, increase in awareness programs, initiatives by public and private organizations, use of combination drug therapy, and use of biomarkers and imaging techniques for diagnosis and management are expected to offer growth opportunities.

1 views • 3 slides

This collaborative project aims to utilize circulating autoantibody biomarkers for the early detection of ovarian cancer, highlighting the importance of screening due to the high curability rates in early stages and the need to improve survival rates by identifying preclinical disease sooner. The pr

3 views • 31 slides

Master protocols, seamless trials, and adaptive designs are revolutionizing oncology drug development. These innovative approaches involve multiple substudies with different objectives, evaluating investigational drugs across disease subtypes. Basket trials and umbrella trials offer flexibility in s

0 views • 13 slides

The study explores the use of ginger supplements in managing diabetes, highlighting the significant impact of the disease on cost and quality of life. It includes details on the controlled crossover study conducted with participants taking ginger root powder capsules, the measurements of oxidative b

0 views • 8 slides

This study evaluates the impact of pesticide exposure on farmers' health in Malaysia, Uganda, and the UK using urinary biomarker concentrations. Multiple cohorts are analyzed to assess associations between exposure-modifying factors and urine metabolite measurements. The IMPRESS project focuses on i

0 views • 12 slides

Clinicians traditionally diagnose Alzheimer's Disease (AD) based on clinical criteria, but cerebrospinal fluid (CSF) AD biomarkers offer more reliable detection earlier in the disease course. This article discusses the criteria for lumbar puncture and CSF analysis in the diagnosis of AD, highlightin

0 views • 18 slides

Explore the methodology of hypothesis-free searching for biomarkers in large imaging datasets using Singular Value Decomposition (SVD). Dr. J. Bruce Morton and Daamoon Ghahari delve into the application of SVD and General Linear Modeling to identify potential biomarkers for ADHD and other neuropsych

0 views • 12 slides

This Phase 2 clinical trial compares the efficacy of NGM282 (3 mg vs 6 mg) versus placebo in patients with NASH. The primary endpoint is a 5% reduction in liver fat content at 12 weeks. Randomisation was stratified by diabetes status, and stable Type 2 diabetes and lipid-lowering treatments were mai

0 views • 6 slides

This document outlines two projects conducted by the GI Collaborative Group focused on detecting and monitoring colorectal cancer using plasma protein markers and ctDNA/aberrantly methylated DNA markers. Project 1 aims to develop a panel of plasma biomarkers for the detection of adenomas and CRC, wh

0 views • 7 slides

This presentation proposes a new topic group on using artificial intelligence for analyzing human voice as a biomarker in disease prevention, prediction, and monitoring. The focus is on addressing challenges in developing AI solutions for clinical applications, with simulations depicting brain activ

0 views • 13 slides

In biogeochemistry research, advanced analytical techniques are utilized to isolate and separate organic matter, focusing on major carbon pools in bodies of water like Lake Superior. Biomarkers such as fatty acids and specific compounds are identified as indicators for various microbial processes, i

0 views • 11 slides

This presentation provides an in-depth overview of assessing alcohol use outcomes in substance use disorder (SUD) trials. It covers various assessment methods, common outcomes like percent days abstinent and heavy drinking days, preferred outcomes such as percentage of heavy drinking days (PHDD), an

0 views • 19 slides

In today's health landscape, trends show a rise in chronic diseases and an aging population, leading to a decentralized healthcare approach. Introducing EGOO, a mobile test unit with smart software for personalized diagnostics. With easy sampling methods and advanced optics to measure biomarkers, it

0 views • 25 slides

Workshop focused on analyzing circulating miRNA changes associated with Alzheimer's and Parkinson's diseases using the Genboree Workbench and exceRpt small RNA-seq analysis pipeline. The study aimed to identify extracellular miRNA biomarkers correlating with disease status and progression, replicati

0 views • 20 slides

The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing began in 2006 with PiB and MRI assessments. Over time, the study has expanded to include more participants and various imaging modalities. Current focuses include converting amyloid results to centiloid units, exploring blood b

1 views • 7 slides

This presentation discusses the use of serosurveillance in household surveys to supplement vaccination data collection by testing for biomarkers indicative of vaccination history. It explores the ideal biomarker for vaccination, differences between serosurveillance and vaccination coverage, limitati

0 views • 8 slides

Biomarkers and maturity parameters play crucial roles in characterizing source materials and assessing the thermal maturity of organic matter in petroleum exploration. Specific biomarkers and non-biomarker maturity parameters are utilized to determine the relative maturity of source rocks and oils.

0 views • 17 slides

This study examines the assessment of liver steatosis in obese children using MRI, ultrasound, and biology techniques, evaluating methods such as attenuation coefficient and proton density fat fraction. The aim is to develop noninvasive biomarkers and validate existing scores for predicting NAFLD. P

0 views • 22 slides

This update discusses the goals of the Biostatistics Core in integrating data from various sources for clinical trial design, assessing biomarkers and clinical measures, and identifying subgroups in MCI. The update also introduces a new measurement, the Financial Capacity Instrument, and shares prel

0 views • 22 slides

Ongoing breast cancer research projects focusing on biomarker validation, new team initiatives, and imaging advancements are detailed. Notable efforts include the investigation of triple-negative breast cancer markers, benign breast disease progression markers, ER+ and HER2+ biomarkers, and breast c

0 views • 9 slides

Explore the expectations and initiatives of QIBA in Japan, focusing on improving biomarkers, enhancing clinical decisions, and setting standards for performance metrics. Learn how QIBA aims to address sources of variance, optimize procedures, and ensure quality in radiological imaging practices.

0 views • 19 slides

The Prostate Collaborative Group is actively working on various research projects related to the detection and evaluation of prostate cancer biomarkers. Updates on research statuses, innovative imaging and urine testing methods, development of protein biomarkers, and biomarkers for early detection o

0 views • 8 slides

Biomarkers are either released by the human body in response to various diseases or by organs that are affected by the disease, such as tumors. Biomarkers are being used increasingly to detect several infectious and chronic diseases, such as cancer,

0 views • 5 slides